ICD-10 Code C90.12 | Plasma cell leukemia in relapse Symptoms, Diagnosis, Billing

Plasma cell leukemia in relapse is a rare and aggressive form of blood cancer characterized by the proliferation of malignant plasma cells in the peripheral blood. This condition often arises from multiple myeloma and signifies a poor prognosis. Accurate coding with ICD-10 Code C90.12 is essential for effective diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track treatment outcomes and resource utilization.

What is ICD-10 Code C90.12 for Plasma cell leukemia in relapse?

ICD-10 Code C90.12 specifically denotes Plasma cell leukemia in relapse, indicating a recurrence of this aggressive hematological malignancy. This code is utilized in clinical documentation and billing when a patient presents with symptoms or complications associated with the relapse of plasma cell leukemia, ensuring accurate representation of the patient's condition for treatment planning and reimbursement purposes.

ICD-10 Code C90.12 – Clinical Definition and Explanation of Plasma cell leukemia in relapse

Plasma cell leukemia in relapse is characterized by the presence of an increased number of malignant plasma cells in the bloodstream, often following a period of remission. This condition requires immediate medical intervention due to its aggressive nature and potential complications. The relapse can be triggered by various factors, including treatment resistance and disease progression.

Key Clinical Features:

• Elevated levels of monoclonal protein in serum or urine.
• Anemia, thrombocytopenia, and leukopenia due to bone marrow infiltration.
• Symptoms of hypercalcemia, such as confusion and dehydration.
• Frequent infections due to compromised immune function.

ICD-10 Code C90.12 for Plasma cell leukemia in relapse – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code C90.12 is crucial for documenting the patient's symptoms, assessment findings, and treatment plans. It aids in tracking the disease's progression and response to therapy, relevant in both acute and chronic care settings.

What Does ICD-10 Code C90.12 for Plasma cell leukemia in relapse Mean in SOAP Notes?

ICD-10 Code C90.12 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of plasma cell leukemia in relapse. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C90.12 – Plasma cell leukemia in relapse

Plasma cell leukemia in relapse necessitates urgent medical intervention, often requiring hospitalization for intensive treatment. Management strategies focus on chemotherapy and supportive care.

Antibiotic Therapy:

• First-line: Piperacillin-tazobactam (Zosyn) for 7-14 days.
• Alternative: Meropenem for 7-14 days if resistant.
• Consideration of prophylactic antibiotics in immunocompromised patients.

Supportive Care:

• Blood transfusions for anemia management.
• Platelet transfusions for thrombocytopenia.
• Hydration and electrolyte management to prevent complications.

Infection Control:

• Strict hand hygiene protocols.
• Isolation precautions for neutropenic patients.
• Vaccination updates as per guidelines.

How to Document Symptoms of Plasma cell leukemia in relapse (ICD-10 C90.12) in SOAP Notes

Subjective:

• Patient reports increased fatigue and weakness.
• History of recurrent infections over the past month.
• Complaints of bone pain and night sweats.
• Patient expresses concern about weight loss.

Objective:

• Vital signs: BP 110/70 mmHg, HR 95 bpm, Temp 99.5°F.
• CBC shows hemoglobin 8.5 g/dL, platelets 50,000/mm³.
• Peripheral blood smear reveals >20% plasma cells.
• Elevated serum calcium level at 12.5 mg/dL.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Plasma cell leukemia in relapse (ICD-10 Code C90.12)

Assessment:

• Diagnosis: Plasma cell leukemia in relapse, severe.
• ICD-10 Code: C90.12.
• Triggers: Previous treatment failure and disease progression.
• Complications: Risk of severe infections and anemia.

Plan:

• Initiate chemotherapy regimen (e.g., bortezomib-based therapy).
• Administer supportive care including blood products as needed.
• Educate patient on signs of infection and when to seek care.
• Schedule follow-up in one month for reassessment.

Treatment & Plan Section for ICD-10 Code C90.12 – Plasma cell leukemia in relapse

• First-line pharmacologic treatment includes bortezomib and dexamethasone.
• Non-pharmacologic strategies involve nutritional support and pain management.
• Monitoring includes regular CBC and serum protein electrophoresis.
• Follow-up practices should include monthly evaluations and adjustment of therapy based on response.

Using ICD-10 Code C90.12 for Plasma cell leukemia in relapse in Billing & SOAP Note Compliance

• Select accurate subcodes based on clinical severity or complications.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• Only list CPT codes that are commonly billed with ICD-10 Code C90.12 based on standard medical coding practices.

Related ICD-10 Codes Often Used with Plasma cell leukemia in relapse

• C90.11 – Plasma cell leukemia, not having achieved remission
• C90.10 – Multiple myeloma, not having achieved remission

ICD-10 Code C90.12 in Medical Billing and Insurance for Plasma cell leukemia in relapse

ICD-10 Code C90.12 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure comprehensive documentation of clinical findings and treatment plans.
• Use the code in settings where plasma cell leukemia in relapse is diagnosed or treated.
• Highlight key elements in the chart that support the diagnosis and treatment rationale.
• Maintain compliance with payer-specific guidelines for coding and billing.

Common CPT Pairings: